The NADPH Oxidase Nox2 Mediates Vitamin D-Induced Vascular Regeneration in Male Mice

Abstract

1α,25-dihydroxy-vitamin D3 (1,25D) exerts protective effects in the vascular system and promotes myeloid cell differentiation, which are important sources of reactive oxygen species. Given that myeloid cell reactive oxygen species derives from Nox-family NADPH oxidases, we hypothesized that this enzyme family contributes to the beneficial effects of 1,25D on vascular regeneration. The function of Nox enzymes in this context was studied in the murine carotid artery electric injury regeneration model. Male mice were treated with daily injections of 1,25D (100 ng/kg · d) for 5 days and carotid injury was induced after 3 days. After injury, 1,25D increased the expression of Nox2 in the carotid artery. As determined by Evans blue staining on day 6, 1,25D improved vascular regeneration in a Nox2-dependent manner. Healing was lost in mice knockout for Nox2, but not in Nox1 or Nox4, knockout mice. Tissue specific knockouts demonstrated that the myeloid, but not the endothelial Nox2, was required for this effect. Mechanistically, the combination of injury and 1,25D induced the mobilization of angiogenic myeloid cells (AMCs) and increased the vascular expression of the cytokine stem cell derived factor (SDF)1, which attracts AMCs to the site of injury. Vitamin D in a Nox2-dependent manner activated MAPKs, and these are known to contribute to SDF1 induction. Accordingly, SDF1 induction was lost after deletion of Nox2. By inducing SDF1 and enhancing the number of AMCs, VitD3 is a novel approach to promote vascular repair.

Damage-induced reactive oxygen species regulate vimentin and dynamic collagen-based projections to mediate wound repair

“…Wound-induced release of ROS has been shown to be a key regulator of wound healing and regeneration ( Leisegang et al, 2016 ; Serras, 2016 ; Yoo et al, 2012 ). Our earlier work demonstrated that early ROS signaling immediately before and after damage, mediated fin regeneration three days later ( Yoo et al, 2012 ).…”

Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects

“…In addition, VD modulates the vascular effects of AGEs by reducing the diabetes-induced increase of IL-6 and of NFκB-p65 DNA binding activity, both key mediators of AGEs signalling [135]. AGEs and RAGE are among the major pathways involved in the pathophysiology of diabetic complications and of DR [136], as their interaction induces the translocation of NF-κB, and the subsequent transcription of endothelial dysfunction biomarkers, such as intercellular adhesion molecule-1 (ICAM-1), endothelin-1, and E-selectin [137].…”